Wuhan Keqian Biology Co Ltd (688526) - Total Liabilities

Latest as of September 2025: CN¥580.21 Million CNY ≈ $84.90 Million USD

Based on the latest financial reports, Wuhan Keqian Biology Co Ltd (688526) has total liabilities worth CN¥580.21 Million CNY (≈ $84.90 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 688526 net asset momentum to track the company's year-over-year net asset growth rate.

Wuhan Keqian Biology Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Wuhan Keqian Biology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 688526 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Wuhan Keqian Biology Co Ltd Competitors by Total Liabilities

The table below lists competitors of Wuhan Keqian Biology Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
NTG Nordic Transport Group A/S CO:NTG	Denmark	Dkr4.92 Billion
Jiangxi Black Cat Carbon Black SHE:002068	China	CN¥5.90 Billion
Leshan Electric Power Co Ltd SHG:600644	China	CN¥2.35 Billion
Flotek Industries Inc NYSE:FTK	USA	$113.67 Million
One United Properties SA RO:ONE	Romania	RON2.72 Billion
Shandong Jinjing Science and Technology Stock Co Ltd SHG:600586	China	CN¥3.88 Billion
CH. Karnchang Public Company Limited BK:CK-R	Thailand	฿89.64 Billion
Eletromidia S.A SA:ELMD3	Brazil	R$2.00 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Wuhan Keqian Biology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688526 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.30	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.14	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.12	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Wuhan Keqian Biology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Wuhan Keqian Biology Co Ltd (2016–2024)

The table below shows the annual total liabilities of Wuhan Keqian Biology Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥552.80 Million ≈ $80.89 Million	-33.68%
2023-12-31	CN¥833.59 Million ≈ $121.98 Million	-6.51%
2022-12-31	CN¥891.63 Million ≈ $130.47 Million	+56.04%
2021-12-31	CN¥571.41 Million ≈ $83.62 Million	+42.00%
2020-12-31	CN¥402.40 Million ≈ $58.88 Million	+59.38%
2019-12-31	CN¥252.48 Million ≈ $36.95 Million	-28.58%
2018-12-31	CN¥353.51 Million ≈ $51.73 Million	+36.57%
2017-12-31	CN¥258.86 Million ≈ $37.88 Million	+44.61%
2016-12-31	CN¥179.01 Million ≈ $26.19 Million	--

About Wuhan Keqian Biology Co Ltd

SHG:688526 China Biotechnology

Market Cap

$875.81 Million

CN¥5.99 Billion CNY

Market Cap Rank

#9486 Global

#2395 in China

Share Price

CN¥12.84

Change (1 day)

-0.39%

52-Week Range

CN¥11.84 - CN¥19.33

All Time High

CN¥47.40